Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

JAFFAL: detecting fusion genes with long-read transcriptome sequencing.

Nadia M Davidson1,2,3, Ying Chen4, Teresa Sadras5,6

  • 1Peter MacCallum Cancer Centre, Victoria, Australia. davidson.n@wehi.edu.au.

Genome Biology
|January 7, 2022
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.

Nature reviews. Clinical oncology·2026
Same author

Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study.

HemaSphere·2026
Same author

T-ALL: the origin story.

Blood·2026
Same author

Myeloid/lymphoid neoplasms with eosinophilia and ZMYM2::FLT3 fusion: clinical, pathological and molecular clues to a cryptic diagnosis.

Pathology·2026
Same author

A Case of Primary Cutaneous BRAF<sup>V600E+</sup> Langerhans Cell Histiocytosis, With Underlying Chronic Myelomonocytic Leukaemia, Responsive to Dabrafenib With Subsequent Undetectable Circulating Cell Free DNA.

The Australasian journal of dermatology·2026
Same author

Precision-guided therapy in H3K27-altered diffuse midline glioma.

Nature communications·2026

JAFFAL identifies gene fusions from long-read transcriptome sequencing data. This new tool accurately detects full-length fusion isoforms, crucial for cancer diagnostics and therapy development.

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Research

Background:

  • Gene fusions are critical biomarkers and therapeutic targets in cancer.
  • Long-read transcriptome sequencing offers full-length fusion isoform discovery.
  • Existing short-read fusion detection algorithms are ineffective for long reads due to higher error rates.

Purpose of the Study:

  • To develop and validate a novel algorithm, JAFFAL, for identifying gene fusions from long-read transcriptome sequencing data.
  • To address the limitations of current algorithms in handling the complexities of long-read sequencing data for fusion detection.

Main Methods:

  • JAFFAL algorithm development for long-read transcriptome data.
  • Validation using simulated data, cell lines, and patient samples from Nanopore and PacBio sequencing platforms.
Keywords:
FusionsLong readsNanoporePacBioRNA sequencingTranslocations

Related Experiment Videos

  • Application of JAFFAL to single-cell RNA sequencing data to identify complex rearrangements.

    • Main Results:

    • JAFFAL successfully identifies gene fusions from long-read transcriptome sequencing.
    • The algorithm demonstrates robust performance across various validation datasets.
    • Complex rearrangements involving three genes were detected using JAFFAL in single-cell data.

    Conclusions:

    • JAFFAL is an effective tool for discovering full-length gene fusion isoforms from long-read sequencing.
    • This advancement facilitates improved cancer diagnostics and the identification of novel therapeutic targets.
    • JAFFAL enables the detection of complex genomic rearrangements previously challenging to identify.